First report of ciprofloxacin-resistant Salmonella Enteritidis isolated from human cases in Morocco

Hajar Elmourabit1, Bouchra Karraouane2, Brahim Bouchrif2

  • 1Laboratory of Plant Biotechnology, Faculty of Sciences, Ibn Zohr University, box 8106, Agadir, Morocco.

Abstract

Insights

The first ciprofloxacin-resistant Salmonella Enteritidis strain was identified in Morocco. This finding underscores the need for enhanced surveillance of antimicrobial resistance in Salmonella to prevent further spread.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • Salmonella Enteritidis is a major cause of global foodborne and invasive infections.
  • Ciprofloxacin is a key treatment for invasive Salmonella, but resistance is a growing concern.
  • No ciprofloxacin-resistant S. Enteritidis had been reported in Morocco prior to this study.

Purpose of the Study:

  • To report the first instance of ciprofloxacin-resistant Salmonella Enteritidis in Morocco.
  • To characterize the genetic basis of ciprofloxacin resistance in this isolate.
  • To emphasize the need for improved surveillance of antimicrobial resistance.

Main Methods:

  • Sixty Salmonella strains were isolated from clinical samples in Marrakech (2018-2024).
  • Antimicrobial susceptibility testing (disk diffusion) and whole-genome sequencing were performed.
  • Genomic analysis identified resistance and virulence genes using ResFinder, PlasmidFinder, and VFDB.

Main Results:

  • Three isolates (5%), including strain S54, exhibited resistance to ciprofloxacin.
  • Genomic analysis revealed a gyrA D87Y mutation and efflux genes (mdsA, mdsB).
  • Virulence genes located in SPI-1 and SPI-2 were also detected.

Conclusions:

  • This study documents the first ciprofloxacin-resistant S. Enteritidis strain identified in Morocco.
  • The findings highlight the critical need for enhanced molecular surveillance.
  • Preventive strategies against fluoroquinolone-resistant Salmonella are urgently required.